WS
ZBH icon

Wedbush Securities’s Zimmer Biomet ZBH Stock Holding History

Wedbush Securities’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,612
Closed -$345K – 1302
2024
Q1 		$345K Buy
2,612
+472
+22% +$59K 0.01% 807
2023
Q4 		$260K Sell
2,140
-192
-8% -$21.4K 0.01% 836
2023
Q3 		$262K Sell
2,332
-427
-15% -$54.2K 0.01% 786
2023
Q2 		$402K Sell
2,759
-3
-0.1% -$408 0.02% 629
2023
Q1 		$357K Buy
2,762
+189
+7% +$23.7K 0.02% 678
2022
Q4 		$328K Sell
2,573
-43
-2% -$4.99K 0.02% 697
2022
Q3 		$273K Buy
2,616
+40
+2% +$4.39K 0.02% 766
2022
Q2 		$271K Buy
2,576
+217
+9% +$25.7K 0.01% 790
2022
Q1 		$302K Sell
2,359
-71
-3% -$8.56K 0.01% 789
2021
Q4 		$300K Sell
2,430
-86
-3% -$11.3K 0.01% 871
2021
Q3 		$358K Buy
2,516
+20
+0.8% +$2.94K 0.02% 765
2021
Q2 		$390K Sell
2,496
-28
-1% -$4.54K 0.02% 730
2021
Q1 		$392K Buy
+2,524
New +$391K 0.02% 671
2020
Q2 		– Sell
-2,914
Closed -$286K – 1018
2020
Q1 		$286K Buy
2,914
+132
+5% +$17.3K 0.03% 536
2019
Q4 		$404K Sell
2,782
-253
-8% -$34.9K 0.04% 551
2019
Q3 		$405K Buy
3,035
+86
+3% +$11.1K 0.04% 523
2019
Q2 		$337K Sell
2,949
-181
-6% -$21.2K 0.03% 586
2019
Q1 		$388K Buy
3,130
+120
+4% +$13.6K 0.04% 507
2018
Q4 		$303K Buy
3,010
+303
+11% +$34.1K 0.04% 536
2018
Q3 		$346K Sell
2,707
-51
-2% -$6.06K 0.04% 527
2018
Q2 		$298K Buy
2,758
+105
+4% +$11.4K 0.04% 558
2018
Q1 		$281K Hold
2,653
– – 0.04% 555
2017
Q4 		$311K Sell
2,653
-3
-0.1% -$339 0.04% 531
2017
Q3 		$302K Buy
2,656
+123
+5% +$14.2K 0.04% 548
2017
Q2 		$316K Hold
2,533
– – 0.04% 524
2017
Q1 		$300K Buy
2,533
+52
+2% +$5.89K 0.04% 535
2016
Q4 		$249K Buy
2,481
+847
+52% +$90.8K 0.04% 582
2016
Q3 		$206K Buy
+1,634
New +$202K 0.03% 669

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wedbush Securities's ZBH Position: Q2 2024 in Review

Wedbush Securities sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 2,612 shares — an estimated $345K sold.

Wedbush Securities first reported a position in ZBH in Q3 2016 and held it in 28 quarters. The position peaked at $405K in Q3 2019. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Wedbush Securities reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Wedbush Securities sold 2,612 Zimmer Biomet shares in Q2 2024, an estimated $345K.
  • Wedbush Securities first reported a position in Zimmer Biomet in Q3 2016 and held it in 28 quarters.
  • Wedbush Securities's Zimmer Biomet position peaked at $405K in Q3 2019.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Wedbush Securities's 13F filing for Q2 2024, filed 7 Aug 2024.